This site is intended for healthcare professionals only
LoginRegister
Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 millionSandoz confirms European Commission nod of Pyzchiva
Zydus Lifesciences launches Mirabegron ER Tablets in US for overactive bladder treatmentZydus Lifesciences launches Mirabegron ER Tablets in US for overactive bladder treatment
Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical NegligenceTrademark Tussle: HC bars Glenmark from using Indamet, says similar to Sun Pharma's anti-diabetes...
ZydusZydus Lifesciences arm gets marketing nod for Nulibry from UK MHRA for MoCD Type A
Lupin receives positive EMA comittee opinion for eye therapy RanluspecLupin unveils Mirabegron ER tablets in US
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureSubmit post-marketing safety data of Belumosudil in Chronic graft versus host disease: CDSCO Panel...
Merck unveils all-in-one genetic stability assay to accelerate biosafety testingMerck unveils all-in-one genetic stability assay to accelerate biosafety testing
Novartis concludes acquisition of Tourmaline BioNovartis Gets CDSCO Panel Nod to Study anti-cancer drug Ribociclib
Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion dealCDSCO Panel Approves Eli Lilly's protocol amendment proposal for Adjuvant Imlunestrant vs Standard...
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales WarningNovo Nordisk Gets CDSCO Panel Nod to Study new medicine NNC0519-0130
CDSCO Panel Flags Ethnic Variability, Seeks More Data from Takeda for Fruquintinib Hard Capsule ApprovalTakeda gets USFDA nod for Entyvio subcutaneous administration for Crohn's disease
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyDr Reddy's Laboratories gets CDSCO Panel Nod To Import and Market Toripalimab 240mg solution for...
X